Variables | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95%CI) | P | HR (95%CI) | P | |
I-III stage | ||||
 Age (≥55 vs. < 55) | 0.832(0.447-1.548) | 0.562 | 0.808(0.416-1.572) | 0.53 |
 Sex (Male vs. Female) | 0.842(0.453-1.566) | 0.587 | 1.166(0.596-2.284) | 0.653 |
 TNM stage (I-III) | 2.157(1.359-3.423) | 0.001** | 2.208(1.368-3.562) | 0.001** |
 MACC1 expression(high vs. low and negative) | 2.144(1.160-3.963) | 0.015* | 2.004(1.054-3.809) | 0.034* |
 MACC1-AS1 expression (high vs. low and negative) | 2.194(1.218-3.952) | 0.009** | 1.913(1.041-3.516) | 0.037* |
IV stage | ||||
 Age (≥55 vs. < 55) | 1.121(0.493-2.546) | 0.786 | 1.722(0.675-4.395) | 0.255 |
 Sex (Male vs. Female) | 0.971(0.423-2.226) | 0.944 | 2.162(0.726-6.445) | 0.166 |
 MACC1 expression((high vs. low and negative) | 2.751(1.155-6.554) | 0.022* | 2.889(1.122-7.443) | 0.028* |
 MACC1-AS1 expression (high vs. low and negative) | 2.572(1.162-5.692) | 0.020* | 2.509(1.025-6.143) | 0.044* |